Last checked at 10 Mar 2023 11:45
Convatec Group PLC (CTEC) Convatec Group PLC: Director/PDMR Shareholding 10-March-2023 / 11:45 GMT/BST 10 March 2023 Convatec Group Plc(“Convatec” or “the Company”) Director/ PDMR Shareholding The Company has been notified of the following transactions in relation to a Person Discharging Managerial Responsibility (“PDMR”) in respect of ordinary shares of 10 pence each in the Company (“Shares”). On 9 March 2023, Shares awarded to Karim Bitar, the Company’s Chief Executive Officer on 6 March 2020 under the Company’s Deferred Bonus Plan vested, resulting in Karim receiving 59,055 Shares. On the same date, 27,833 of these Shares were sold automatically on Karim’s behalf to satisfy income tax and national insurance liabilities arising in connection with the vesting of this award. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
Enquiries
Louise Bryson, Assistant Company Secretary +44(0)7423 694919
Cosec@convatec.com
Convatec Group Plc’s LEI code is 213800LS272L4FIDOH92
About Convatec Pioneering trusted medical solutions to improve the lives we touch: Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in advanced wound care, ostomy care, continence and critical care, and infusion care. With around 10,000 colleagues, we provide our products and services in almost 100 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention and protection of at-risk skin, to improved patient outcomes and reduced care costs. Group revenues in 2022 were over $2 billion. The company is a constituent of the FTSE 100 Index (LSE:CTEC). To learn more about Convatec, please visit http://www.convatecgroup.com.
Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ISIN: | GB00BD3VFW73 |
| Category Code: | DSH |
| TIDM: | CTEC |
| LEI Code: | 213800LS272L4FIDOH92 |
| OAM Categories: | 3.1. Additional regulated information required to be disclosed under the laws of a Member State |
| Sequence No.: | 229120 |
| EQS News ID: | 1579993 |
| End of Announcement | EQS News Service |
UK Regulatory announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.